News

Risk Factors Quantified for Hepatitis C

Author and Disclosure Information

 

FROM ANNALS OF INTERNAL MEDICINE

References

The risk factors most associated with chronic hepatitis C virus infection in Americans aged 20-59 years are age 40-59 years, illicit drug use other than marijuana, and family income less than twice the poverty level, according to investigators from the Centers for Disease Control and Prevention.

Data from 10,941 participants in the National Health and Nutrition Examination Survey (2003-2010) show that those aged 50-59 years were 9.5 times more likely and those aged 40-49 were 6.0 times more likely to have HCV infection than 20- to 39-years-olds, reported Dr. Maxine M. Denniston and her associates (Ann. Intern. Med. 2014;160:293-300).

Survey respondents who reported lifetime drug use other than marijuana (including injection drugs) were 8.7 times more likely to have chronic HCV than those with no drug use or marijuana use only, and those with a family income less than twice the poverty level were 3.7 times more likely to have HCV than were those with incomes more than twice the poverty level, the investigators reported.

Other statistically significant risk factors include male sex (odds ratio, 1.6), non-Hispanic black race/ethnicity (OR, 1.6), and high school education or less (OR, 2.0), they said.

Recommended Reading

New drug for hepatitis C may put treatment in the hands of primary care
Clinician Reviews
FDA panel backs approval of new protease inhibitor for hepatitis C
Clinician Reviews
Once-a-day HCV Protease Inhibitor Approved for Treating Hepatitis C
Clinician Reviews
How to Manage Anemia From HCV Treatment
Clinician Reviews
Drug Combo Effective in Resistant Hepatitis C
Clinician Reviews
Interferon-free Oral Regimen Effective in Hepatitis C, HIV Coinfected
Clinician Reviews
ECHO Model Cost-effective for HCV
Clinician Reviews
Boceprevir, Telaprevir Linked to Anemia in HCV-infected Seniors
Clinician Reviews
New Drugs Trump Interferon in HCV Therapy
Clinician Reviews
The Price and Cost of Hepatitis C Treatment
Clinician Reviews